Department of Chemistry, Chemistry Building, Michigan State University, Room 426, 578 S. Shaw Lane, East Lansing, MI 48824, USA.
Nanoscale. 2013 May 7;5(9):3895-903. doi: 10.1039/c3nr33777d. Epub 2013 Mar 26.
Nanoparticles (NPs) are being extensively studied as carriers for drug delivery, but they often have limited penetration inside tumors. We envision that by targeting an endocytic receptor on the cell surface, the uptake of NPs can be significantly enhanced through receptor mediated endocytosis. In addition, if the receptor is recycled to the cell surface, the NP cargo can be transported out of the cells, which is then taken up by neighboring cells thus enhancing solid tumor penetration. To validate our hypothesis, in the first of two articles, we report the synthesis of doxorubicin (DOX)-loaded, hyaluronan (HA) coated silica nanoparticles (SNPs) containing a highly fluorescent core to target CD44, a receptor expressed on the cancer cell surface. HA was conjugated onto amine-functionalized SNPs prepared through an oil-water microemulsion method. The immobilization of the cytotoxic drug DOX was achieved through an acid sensitive hydrazone linkage. The NPs were fully characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), zeta potential measurements, thermogravimetric analysis (TGA), UV-vis absorbance, and nuclear magnetic resonance (NMR). Initial biological evaluation experiments demonstrated that compared to ligand-free SNPs, the uptake of HA-SNPs by the CD44-expressing SKOV-3 ovarian cancer cells was significantly enhanced when evaluated in the 2D monolayer cell culture. Mechanistic studies suggested that cellular uptake of HA-SNPs was mainly through CD44 mediated endocytosis. HA-SNPs with immobilized DOX were endocytosed efficiently by the SKOV-3 cells as well. The enhanced tumor penetration and drug delivery properties of HA-SNPs will be evaluated in 3D tumor models in the subsequent paper.
纳米粒子(NPs)作为药物递送的载体正在被广泛研究,但它们通常在肿瘤内部的穿透能力有限。我们设想,通过靶向细胞表面上的内吞受体,通过受体介导的内吞作用,可以显著增强 NPs 的摄取。此外,如果受体被回收至细胞表面,则可以将 NP 货物运出细胞,然后被邻近细胞摄取,从而增强实体瘤的穿透性。为了验证我们的假设,在两篇文章中的第一篇中,我们报告了载有阿霉素(DOX)的透明质酸(HA)涂覆的二氧化硅纳米粒子(SNPs)的合成,该粒子含有一个高度荧光的核,以靶向 CD44,这是一种在癌细胞表面表达的受体。HA 通过油-水微乳液法连接到胺功能化的 SNPs 上。通过酸敏感的腙键实现了细胞毒性药物 DOX 的固定化。通过透射电子显微镜(TEM)、动态光散射(DLS)、zeta 电位测量、热重分析(TGA)、紫外可见吸收和核磁共振(NMR)对 NPs 进行了全面表征。初步的生物学评价实验表明,与无配体的 SNPs 相比,在 2D 单层细胞培养中评估时,表达 CD44 的 SKOV-3 卵巢癌细胞对 HA-SNPs 的摄取明显增强。机制研究表明,HA-SNPs 的细胞摄取主要通过 CD44 介导的内吞作用。具有固定 DOX 的 HA-SNPs 也被 SKOV-3 细胞有效地内吞。HA-SNPs 的增强的肿瘤穿透性和药物递送特性将在后续论文中的 3D 肿瘤模型中进行评估。